Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Bruker (BRKRP) Cost of Revenue (2016 - 2025)

Historic Cost of Revenue for Bruker (BRKRP) over the last 17 years, with Q3 2025 value amounting to $481.1 million.

  • Bruker's Cost of Revenue rose 796.68% to $481.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 billion, marking a year-over-year increase of 980.78%. This contributed to the annual value of $1.7 billion for FY2024, which is 1830.9% up from last year.
  • Latest data reveals that Bruker reported Cost of Revenue of $481.1 million as of Q3 2025, which was up 796.68% from $439.5 million recorded in Q2 2025.
  • In the past 5 years, Bruker's Cost of Revenue registered a high of $486.3 million during Q4 2024, and its lowest value of $276.0 million during Q1 2021.
  • Its 5-year average for Cost of Revenue is $364.9 million, with a median of $342.5 million in 2022.
  • As far as peak fluctuations go, Bruker's Cost of Revenue changed by 0.0% in 2022, and later skyrocketed by 2385.4% in 2023.
  • Over the past 5 years, Bruker's Cost of Revenue (Quarter) stood at $341.9 million in 2021, then grew by 0.18% to $342.5 million in 2022, then grew by 23.85% to $424.2 million in 2023, then rose by 14.64% to $486.3 million in 2024, then dropped by 1.07% to $481.1 million in 2025.
  • Its Cost of Revenue stands at $481.1 million for Q3 2025, versus $439.5 million for Q2 2025 and $410.2 million for Q1 2025.